A small device in the ear.. Does it open a new door for treating high blood pressure?

However, the picture is not conclusive; the device did not show a statistically significant superiority over the placebo device when evaluating all participants. This means that the technology is still in the research stage and has not yet been proven effective as a treatment for high blood pressure.

The technology relies on stimulating nerves in the ear that are connected to the pathways of the autonomic nervous system, which is involved in regulating essential functions, including heart rate, blood vessel activity, and blood pressure.

The vagus nerve plays an important role in regulating heart functions and communication between the brain and body organs, within a complex network of nerve signals that help adjust the body's response to various conditions.

To utilize these pathways, researchers used a small device that sends low-intensity electrical pulses through two clips placed on a cartilaginous part at the entrance of the ear known as the "tragus."

This method aims to modulate the activity of neural pathways associated with heart and circulatory regulation, which may help lower blood pressure in some patients.

One of the most prominent advantages of the technology is that it does not require surgery or the implantation of electrodes inside the body, as the device can be used externally. However, its ease of use does not necessarily mean its therapeutic efficacy is proven.

The study included 63 patients suffering from uncontrolled high blood pressure, despite taking at least one medication to lower it.

The researchers randomly divided the participants into two groups; the first used the actual electrical stimulation device, while the second used a placebo device for comparison, with the aim of distinguishing between the potential effect of the stimulation itself and changes that might occur for other reasons.

Participants used the device for 30 minutes daily during the first two weeks, then once weekly over ten additional weeks.

The results showed that the device was safe and well-tolerated during the study period, and participants were able to use it at home without significant difficulties.

But when comparing the two groups, the researchers did not find a statistically significant difference in the reduction of blood pressure among the participants as a whole.

In contrast, a pre-planned subgroup analysis showed that participants whose blood pressure readings were higher at the start of the trial recorded a greater decrease with the actual stimulation.

This result suggests the possibility that a specific category of patients might benefit more from the technology, but it is not enough on its own to prove efficacy, especially since the number of participants in the study was limited.

The answer currently is no.

The study did not prove that the device is capable of controlling blood pressure in all patients, nor did it test whether its use reduces the risk of long-term complications, such as heart attacks and strokes.

Ear-based nerve stimulation may become an adjunctive treatment option in the future, if larger and more comprehensive trials confirm its efficacy and identify the patients who would benefit most from it.

For the time being, blood pressure medications should not be stopped or their dosages adjusted based on these results; rather, one should continue the prescribed treatment and consult a doctor when necessary.

Blood pressure control remains dependent on a set of measures, including adherence to medication, reducing salt intake, regular physical activity, maintaining a healthy weight, and monitoring readings periodically.

The importance of the study lies in the fact that it explores a path relatively different from traditional treatments; instead of relying solely on drugs to affect blood vessels or kidneys, researchers are attempting to modulate the nerve signals that contribute to regulating blood pressure.

This approach may help expand future treatment options, especially for people whose blood pressure remains high despite receiving appropriate treatment.

However, proving this requires larger studies, longer follow-up periods, and clear results regarding the amount of blood pressure reduction, its sustainability, and the safety of long-term use.

The preliminary results open a promising research window, but they do not mean that treating blood pressure has become possible simply by placing a device in the ear. What will determine the value of this technology is its ability to achieve a consistent and medically significant reduction in blood pressure, rather than just showing encouraging results in a limited group of patients.